Skip to content
MARKETS / NASDAQ / ZSTK
NASDAQ · FINANCE SERVICES

ZeroStack Corp. ZSTK

5 fiscal years on record · USD · FY2025 reported · SEC filings only
$35.7M
▼ 0.5% YoY
$-119.7M
$-8.8M
In brief

What this company does

We are a decentralized AI treasury and AI-focused asset management company that is investing in the future of AI. The Company is a global pharmaceutical distributor through its wholly owned subsidiary Phatebo GmbH ("Phatebo"). This pillar is anchored by ZeroStack's wholly owned subsidiary, Phatebo, a multi-national operator in pharmaceutical distribution, with principal operations in Germany. As of December 31, 2025, we had a total of 21 employees, all of which were full-time.

Written from the business description in ZeroStack Corp.'s annual report to the U.S. Securities and Exchange Commission, filed 27 February 2026. Every sentence was checked against that document before publication.

Growth
USD 35.7M
Revenue, FY2025 · full 5-year series below
Revenue $M Net income $M
FY2025 · Revenue 35.7 · Net income -119.7
40M-40M-80M20212022202320242025
Compound annual growth
+2.2%
3 yrs
5 yrs
10 yrs
15 yrs

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability
−336 cents
lost on every revenue dollar
Operating margin Net margin
FY2025 · Operating -433.5% · Net -335.6%
100%200%-200%-400%20212022202320242025
ROE
FY2024 · ROE -291.5%
-100%-200%20212022202320242025

Cash & shareholders
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2025 · FCF -8.8
-10M-20M20212022202320242025
Net buybacks $M Dividends $M
FY2023 · Dividends — · Net buybacks -2.7
-20M-40M202120222023

Total assetsUSD 130.2M
EquityUSD 70.6M
CashUSD 5.6M
Gross debtUSD 53.5M
Net debtUSD 47.9M
Current ratio1.01×

Net debt stands at 68% of equity.

The 5-year record
5 fiscal years
Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative
Metric 20252024202320222021
Revenue $B0.00.00.10.00.0
Operating income $B−0.2−0.0−0.1−0.0−0.0
EBITDA $B−0.2−0.0−0.0−0.0−0.0
Income tax $B0.00.0−0.0−0.0−0.0
Net income $B−0.1−0.0−0.1−0.1−0.0
Free cash flow $B−0.0−0.0−0.0−0.0−0.0
EPS, diluted $−43.49−50.02−7.75−13.68·
Dividend / sh $·····
Payout %·····
ROE %·−291.5−180.4−78.2−27.7
Shares out B0.000.000.010.010.00

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Provenance
Company facts, as filed
How we verify · 0 failures in 24 reconciliationsAUDITED

Reconciled in 5 of 19 fiscal years. 71 checks could not be computed.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures
ActivityFinance Services
Listed onNASDAQ
Incorporated inTexas
Fiscal year endsDecember 31
SEC categoryemerging growth company
Data on record since2021

Share this section

Download image